Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

Stopped This application needs further attention in terms of FDA approval and will be reassigned under a different trial number later.

Conditions

• Hepatocellular Carcinoma

Interventions

• DEVICE: TheraBionic Device
• DEVICE: Placebo Device

Sponsor

Wake Forest University Health Sciences

Collaborators

• [object Object]